The Circular RNA circXPO1 Promotes Tumor Growth via Sponging MicroRNA-23a in Prostate Carcinoma

被引:9
作者
Chen, Haoyan [1 ]
Zhang, Ping [1 ]
Yu, Bo [1 ]
Liu, Jinlong [2 ]
机构
[1] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Pharm, Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Zhangjang Inst, Shanghai, Peoples R China
关键词
circXPO1; microRNA-23a; prostate cancer; therapeutic target; real-time PCR; EXPRESSION; MIR-23A;
D O I
10.3389/fonc.2021.712145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been shown that circular RNA XPO1 (circXPO1) is involved in cancer (e.g., lung adenocarcinoma and osteosarcoma) progression by sponging microRNAs. Nevertheless, the role of circXPO1 and its interaction with microRNAs in prostate cancer remains unknown. In this study, the results of quantitative real-time PCR showed that circXPO1 levels were dramatically increased in human prostate cancer tissue and cell lines compared with those in normal tissue and cell line. Furthermore, cell proliferation, colony formation, and cell invasion assays showed that circXPO1 promoted the malignant behavior of pancreatic cells in vitro. Mechanistically, bioinformatics prediction, a dual-luciferase reporter assay, and pull-down assay suggested that circXPO1 physically targets miR-23a and negatively regulates its expression in pancreatic cancer cells. miR-23a mimics and inhibitors effectively reversed the effects of circXPO1 on the malignant behavior of prostate cancer cells in vitro. Consistent results were observed in the xenograft tumor model. In conclusion, circXPO1 promotes prostate cancer progression via targeting miR-23a, thus suggesting the circXPO1/miR-23a axis can be used as a potential therapeutic target for prostate cancer treatment.
引用
收藏
页数:10
相关论文
共 28 条
[1]   MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches [J].
Aghaee-Bakhtiari, Seyed Hamid ;
Arefian, Ehsan ;
Naderi, Mahmood ;
Noorbakhsh, Farshid ;
Nodouzi, Vahideh ;
Asgari, Mojgan ;
Fard-Esfahani, Pezhman ;
Mahdian, Reza ;
Soleimani, Masoud .
TUMOR BIOLOGY, 2015, 36 (06) :4203-4212
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates [J].
Busetto, Gian Maria ;
Giovannone, Riccardo ;
Antonini, Gabriele ;
Rossi, Antonella ;
Del Giudice, Francesco ;
Tricarico, Stefano ;
Ragonesi, Giulia ;
Gentile, Vincenzo ;
De Berardinis, Ettore .
BJU INTERNATIONAL, 2015, 116 (01) :117-123
[4]   Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) [J].
Busetto, Gian Maria ;
Giovannone, Riccardo ;
Ferro, Matteo ;
Tricarico, Stefano ;
Del Giudice, Francesco ;
Matei, Deliu Victor ;
De Cobelli, Ottavio ;
Gentile, Vincenzo ;
De Berardinis, Ettore .
BMC UROLOGY, 2014, 14
[5]   Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway [J].
Cai, Songwang ;
Chen, Ruihan ;
Li, Xiaojuan ;
Cai, Yi ;
Ye, Zhiqiang ;
Li, Shigeng ;
Li, Jun ;
Huang, Huaiqiu ;
Peng, Shubin ;
Wang, Jun ;
Tao, Yiran ;
Huang, Hongxing ;
Wen, Xinglai ;
Mo, Jianfeng ;
Deng, Zhupeng ;
Wang, Jian ;
Zhang, Yangfan ;
Gao, Xin ;
Wen, Xingqiao .
ONCOTARGET, 2015, 6 (06) :3904-3917
[6]   Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression [J].
Dai, Yuanqing ;
Li, Dongjie ;
Chen, Xiong ;
Tan, Xinji ;
Gu, Jie ;
Chen, Mingquan ;
Zhang, Xiaobo .
MEDICAL SCIENCE MONITOR, 2018, 24 :3462-3471
[7]   Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes [J].
Dalgliesh, Gillian L. ;
Furge, Kyle ;
Greenman, Chris ;
Chen, Lina ;
Bignell, Graham ;
Butler, Adam ;
Davies, Helen ;
Edkins, Sarah ;
Hardy, Claire ;
Latimer, Calli ;
Teague, Jon ;
Andrews, Jenny ;
Barthorpe, Syd ;
Beare, Dave ;
Buck, Gemma ;
Campbell, Peter J. ;
Forbes, Simon ;
Jia, Mingming ;
Jones, David ;
Knott, Henry ;
Kok, Chai Yin ;
Lau, King Wai ;
Leroy, Catherine ;
Lin, Meng-Lay ;
McBride, David J. ;
Maddison, Mark ;
Maguire, Simon ;
McLay, Kirsten ;
Menzies, Andrew ;
Mironenko, Tatiana ;
Mulderrig, Lee ;
Mudie, Laura ;
O'Meara, Sarah ;
Pleasance, Erin ;
Rajasingham, Arjunan ;
Shepherd, Rebecca ;
Smith, Raffaella ;
Stebbings, Lucy ;
Stephens, Philip ;
Tang, Gurpreet ;
Tarpey, Patrick S. ;
Turrell, Kelly ;
Dykema, Karl J. ;
Khoo, Sok Kean ;
Petillo, David ;
Wondergem, Bill ;
Anema, John ;
Kahnoski, Richard J. ;
Teh, Bin Tean ;
Stratton, Michael R. .
NATURE, 2010, 463 (7279) :360-363
[8]   MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4 [J].
Deng, Yi Hui ;
Deng, Zhi Hui ;
Hao, Hu ;
Wu, Xian Lin ;
Gao, Hui ;
Tang, Shao Hui ;
Tang, Hui .
EXPERIMENTAL CELL RESEARCH, 2018, 373 (1-2) :171-179
[9]   miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2 [J].
Diao, Hongliang ;
Ye, Zhou ;
Qin, Renyi .
JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (03) :676-683
[10]   The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncology [J].
Ferro, Matteo ;
Lucarelli, Giuseppe ;
de Cobelli, Ottavio ;
Del Giudice, Francesco ;
Musi, Gennaro ;
Mistretta, Francesco A. ;
Luzzago, Stefano ;
Busetto, Gian M. ;
Buonerba, Carlo ;
Sciarra, Alessandro ;
Conti, Simon ;
Porreca, Angelo ;
Battaglia, Michele ;
Ditonno, Pasquale ;
Manfredi, Matteo ;
Fiori, Cristian ;
Porpiglia, Francesco ;
Terracciano, Daniela .
MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (04) :442-451